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ABSTRACT 
The TNFAIP8 gene family is a recently discovered family of immune-related 
genes that have been implicated in both innate immunity and immune homeostasis.  This 
gene family consists of tumor necrosis factor (TNF)-alpha-induced protein 8 (TNFAIP8), 
TNFAIP8L1 (TIPE1), TNFAIP8L2 (TIPE2), and TNFAIP8L3 (TIPE3), of which only 
two, TNFAIP8 and TIPE2, have been characterized.  Previous studies have revealed high 
sequence homology among family members, as is evident in the collective involvement 
of TNFIAP8 and TIPE2 in critical immune-related diseases, including cancer and 
inflammatory disease, respectively.  However, TIPE1 has been left relatively 
uncharacterized, and its role in the context of antiviral innate immunity has largely been 
unexplored.   
Using RAW264.7 macrophages as an in vitro model and the zebrafish, Danio 
rerio, as an in vivo model, we hope to elucidate the antiviral innate immune function of 
TIPE1.  Morpholino-mediated TIPE1 knockdown resulted in decreased zebrafish survival 
upon influenza infection, suggesting that TIPE1 is a critical antiviral gene.  Additionally, 
through stimulation of certain antiviral pathways in vitro, and subsequent real-time 
quantitative polymerase chain reaction (RT-qPCR), preliminary data has revealed a 
possible inhibitory immune role for TIPE1.  
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INTRODUCTION 
 Nearly 200 different viruses are known to infect humans, causing a variety of 
devastating diseases observed throughout the world.  Despite the prevalence of disease-
causing viruses, vaccines are only available for 15 of these 200 viruses, warranting a 
constant need for new antiviral treatments (Small and Ertl, 2011).  The discovery of 
uncharacterized immune-related genes offers an opportunity for researchers to examine 
possible antiviral function.  If antiviral function is established, these genes and their 
associated proteins may aid in the production of antiviral treatments.   
The antiviral innate response is commonly triggered by the binding of viral 
pathogen associated molecular patterns (PAMPs) to a specific subset of antiviral 
pathogen recognition receptors (PRRs), including members of the Toll-like receptor 
(TLR) and Rig-I-like receptor (RLR) families (Thompson et al., 2011).   Common viral 
PAMPs include single stranded RNA (ssRNA), double stranded RNA (dsRNA), and 
unmethylated CpG DNA motifs.  Upon ligand binding, activated receptors initiate 
downstream signaling cascades consisting of numerous immune-related proteins 
(Thompson et al., 2011).  Interactions between these signaling proteins eventually lead to 
the induction of interferon (IFN) and the subsequent establishment of the ‘antiviral state’ 
(Thompson et al., 2011).  The complex nature of the antiviral signaling pathways leaves 
room for the discovery of new protein-protein interactions, including interactions 
involving recently discovered immune-related proteins.  
 The TNFAIP8 gene family is a recently discovered gene family implicated in 
immunity.  Two members, TNFAIP8 and TIPE2, have been characterized, and their 
associated proteins have known interactions in innate signaling cascades (Lou and Liu, 
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2011). However, tumor necrosis factor (TNF)-alpha-induced protein 8-like 1 
(TNFAIP8L1 or TIPE1) has been left largely uncharacterized since its discovery in 2008 
(Lou and Liu, 2011).  Previous work performed by Dr. Con Sullivan in the Kim lab has 
revealed TIPE1 function in antibacterial innate immunity.  Therefore, it is of great 
interest to investigate the role of TIPE1 in the antiviral innate immune system, with the 
hope that findings will eventually aid in the development of new antiviral treatments.   
 
BACKGROUND 
 Individuals diagnosed with the flu experience headaches, coughing, and overall 
fatigue.  These symptoms are the result of a systemic influenza virus infection, initiated 
through contact with another infected individual.  At the cellular level, the mechanisms 
behind viral entry and replication allow for the propagation of infection, ultimately 
causing the adverse effects experienced by flu patients.  It is the study of these 
mechanisms that is critical in developing antiviral treatments and preventative vaccines. 
 Viruses are the most abundant disease-causing agent on earth.  These obligate 
intracellular parasites manipulate host cell machinery in order to replicate.   Fortunately, 
the host is not left defenseless.  The immune system, divided into the adaptive and innate 
branches, is responsible for identifying and destroying all invading viruses.  Unlike the 
adaptive immune system which is highly specific in nature, the innate immune system is 
the first line of defense, and is conserved across all organisms (Parkin, 2001).  Therefore, 
the study of the innate immune system has universal implications and is often the subject 
of research.   
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 Within the innate immune system, a specific set of pathogen recognition receptors 
(PRRs) are responsible for detecting viral presence through the binding of pathogen 
associated molecular patterns (PAMPs) (Akira et al., 2006).  This includes members of 
the TLR family, such as TLR3, TLR7, TLR8, and TLR9, all found on the endosome.  All 
four receptors are stimulated by different forms of viral genetic material (Thompson et 
al., 2011).  The RLR family of cytosolic RNA sensors are also stimulated by viral genetic 
material.  This includes MDA5, which binds to dsRNA derived from viral genomes.  
Although diverse in structure and location, all stimulated antiviral PRRs activate 
signaling cascades that lead to the production of cytokines and interferons (Thompson et 
al., 2011).  Interferons are subsequently released into the extracellular environment where 
they initiate an antiviral state within neighboring cells (Thompson et al., 2011).   
Two members of the TNFAIP8 gene family, TNFAIP8 and TIPE2, have been 
characterized as negative regulators of apoptosis and inflammation, respectively (Lou and 
Liu, 2011).  Their associated proteins function in innate signaling cascades.  The 
remaining members, TIPE1 and TIPE3, have been left relatively uncharacterized (Lou 
and Liu, 2011).  Previous studies by Dr. Con Sullivan have revealed TIPE1 function in 
both angiogenesis and antibacterial innate immunity.  Therefore, it is of great interest to 
investigate the possibility of antiviral function and associated protein interaction in 
antiviral signaling cascades. 
Due to ethical concerns regarding human testing, the zebrafish is commonly 
employed as a model organism.  Often lauded for its high fecundity, larval transparency, 
external fertilization, and short generation time, the zebrafish has become an established 
human infectious disease model over the past fifteen years (Spence et al., 2008).  On the 
4 
 
other hand, there are many research procedures that are well suited for cell culture, and 
thus it is sometimes important to also employ an in vitro model system. For example, the 
RAW 264.7 mouse macrophage cell line allows for the direct study of immune processes 
and their outcomes through transfection and RNA quantification.   
Together, these two model systems are employed in an attempt to elucidate TIPE1 
antiviral function.  Fortunately, reverse genetics is established in both models, and thus 
the knockdown of TIPE1 expression is utilized as a way of uncovering the role of TIPE1 
in the antiviral innate immune system.     
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VIRUSES 
Viruses are obligatory intracellular parasites composed of a set of nucleic acid 
genes enclosed in a protein capsid.  Due to lack of essential enzyme systems, they 
manipulate host cell machinery to replicate and propagate further infection (Acheson, 
2011).  The common virus replication cycle is as follows: binding of cell receptor and 
entry into the host cell, uncoating of protein capsid, early gene expression using host cell 
machinery, replication of viral genome, late gene expression, assembly of virions, and 
finally, exit of assembled viral progeny and dissemination to other host cells.  This final 
step often results in cell death and thus is the source of most associated disease symptoms 
(Acheson, 2011). 
Viruses infect all 
forms of life, and are the 
cause of many widespread 
and devastating human 
diseases (Fig. 1).  The study 
of viruses has not only aided 
in attempting to eliminate 
some of the worst disease-
causing agents, but has also 
led to a number of critical 
discoveries and developments 
in molecular biology and 
genetics, and will undoubtedly continue to do so in the future (Acheson, 2011).   
Fig. 1 Overview of viral infections in humans 
(Harvey et al., 2007) 
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RAW264.7 CELLS AS A MODEL SYSTEM 
 Tissue culture, which encompasses both organ culture and cell culture, has 
become an increasingly useful biological procedure since its invention in 1907 by Dr. 
Ross Harrison in his study of frog nerve cell development (Freshney, 2010).  Preliminary 
advancements in tissue culture occurred out of a need for antiviral vaccines and an 
understanding of neoplasia, as answers were needed for such significant medical issues 
(Freshney, 2010).  However, over the next century, further developments in tissue culture 
expanded its uses, aiding in a range of biological fields from immunology to tissue 
regeneration (Fig. 2).   
 Cell culture allows for the study of specific biological mechanisms without the 
constraints attributed to working with a living model organism.  Unlike organ culture in 
which the structure of the primary tissue is at least partially retained, cell culture consists 
Fig. 2 Overview of Tissue Culture Applications (Freshney, 2010) 
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of an adherent monolayer of identical cells suspended in a growth medium (Freshney, 
2010).  The environment in which the cells grow can be easily controlled, often leading 
to homogeneity of sample, resulting in very similar if not identical replicates.  In terms of 
experimentation, direct access to the cells allows for exposure to reagents of much lower 
concentrations for much faster times (Freshney, 2010).  Therefore, economically, cell 
culture is a very attractive option.  Moreover, the ability to take a more direct approach in 
answering scientific questions about a specific cell type is extremely useful, as is evident 
in its appeal to an increasing number of individuals (Fig. 3).   
 Many cell lines used in cell culture are continuous, brought about by a genotypic 
change causing an increased rate of cell proliferation, which in turn results in a higher 
plating efficiency.  It has been known that transformed tumor cells give rise to continuous 
cell lines, as was first demonstrated 
with HeLa cells in 1952 (Freshney, 
2010).  Our lab has chosen to work 
with the transformed Abelson 
murine leukemia virus-induced 
tumor macrophage cell line, RAW 
264.7.  These transformed 
macrophages originated from a 
tumor induced by the Abelson 
murine leukemia virus (A-MuLV) in a male BAB/14 mouse (Raschke, 1978).  A-MuLV 
is a replication defective retrovirus capable of transforming fibroblasts, lymphocytes, and 
monocytes.  It is believed that the initial tumor contained both transformed lymphocytes 
Fig. 3 Number of “cell culture” hits in 
PubMed since 1965 
(Freshney, 2010) 
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and monocytes, from which only the transformed monocytes successfully grew in culture 
(Raschke, 1978).   
 RAW264.7 cells display all of the properties found in normal macrophages 
(Raschke, 1978).  This includes the pattern recognition receptors commonly found on 
macrophages and dendritic cells.  This particular cell line also fails to secrete detectable 
numbers of virus particles, which could cause problems in immunological studies 
(Raschke, 1978).  Accordingly, the chosen cell line is an adequate immune cell model 
that allows us to manipulate and analyze target immune-related genes of interest. 
  The limitations of cell culture lead to differences in cell behavior between 
cultured cells and their in vivo counterparts (Freshney, 2010).  These limitations arise 
largely from the dissimilarities between the in vitro and in vivo cellular environments.  
However, the necessary level of expertise, associated costs, dedifferentiation of cells, and 
genetic instability of continuous cell lines also present disadvantages (Freshney, 2010).   
Consequently, although cell culture is an important and extremely useful in vitro tool 
when studying specific biological mechanisms, its limitations reveal the necessity for an 
in vivo model organism.   
 
ZEBRAFISH AS A MODEL ORGANISM 
 Due to ethical considerations concerning human testing, animal models have long 
been used in biomedical research to study human pathologies and infectious diseases, 
including those caused by viruses.  Unlike cell culture, in vivo model organisms are 
complete biological systems with corresponding systemic components including diverse 
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cellular interactions, homeostatic regulation, and three-dimensional cellular geometry; all 
of which are lost when using most in vitro model systems (Freshney, 2010).   
When studying human disease, lower mammalian models are often favored due to 
striking homology between mammalian genomes as well as significant anatomical and 
physiological similarities.  However, physical and financial limitations associated with 
mammalian models have led 
to the use of invertebrates in 
genetic studies (Lieschke and 
Currie, 2007).  A great 
example of the utility of such 
genetic models includes the 
identification of the Toll-like 
receptors (TLRs) through the 
discovery of the Toll gene in 
Drosophila melanogaster 
(Goldsmith and Jobin, 2012).  
Yet, invertebrates lack 
anatomical structures 
involved in human 
pathogenesis, limiting their ability to model human disease.  Surely, all model organisms 
have costs and benefits attributed to them that must be considered for each individual 
study (Fig 4).   
Fig. 4 A comparison of model organisms used in the 
study of human diseases.  The zebrafish is an 
exceptional human disease model 
(Lieschke and Currie, 2007) 
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Fortunately, the lower vertebrate zebrafish presents a viable biological 
compromise, presenting basic physiological similarities with humans while remaining 
extremely cost-effective.  Not surprisingly, the zebrafish model has grown extensively in 
popularity over the last fifteen years, and its uses range from studies in wound healing 
and regeneration to microbe-host interactions (Goldsmith and Jobin, 2012).  Indeed, its 
benefits as a model organism led to its employment as the model for human viral 
infection in the present study.   
Since its genesis as a model organism in the late 1960s through the work of 
George Streisinger (Grunwald and Eisen, 2002), the zebrafish has been praised for its 
high fecundity (100 embryos per clutch), larval transparency (through 7 days post 
fertilization), ease of genetic 
manipulation, and overall 
genetic and organ system 
homology to humans (Fig. 
5).  Additional benefits 
include external fertilization 
(allowing access to all 
developmental stages), short 
generation time (3-4 months), egg size (0.7 mm in diameter), and speed of development 
(all major organs developing within 36 hours post fertilization) (Spence et al., 2008).  
  In regard to the present study, there are many innate characteristics of zebrafish 
that aid in the study of immunity and human disease.  For instance, the zebrafish immune 
system is highly analogous to that of mammals.  The innate immune system is functional 
Fig. 5 The anatomy of the zebrafish.  Some of the 
benefits associated with using this model organism are its 
larval transparency and small size.  Image taken using 
brightfield microscopy 6 days post fertilization.  Scale bar 
is 1 mm.  SB = swim bladder (Goldsmith and Jobin, 
2012) 
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just 48 hours post fertilization, and is composed of neutrophils, natural killer (NK) cells, 
and monocytes (Goldsmith and Jobin, 2012).  A fully functional adaptive immune system 
is generated later in development at 4 to 6 weeks post fertilization (Goldsmith and Jobin, 
2012).   The temporal separation between the different levels allows for the exclusive 
study of factors involved in the innate immune system.  It has also been shown that 
zebrafish contain an almost complete set of TLRs (TLR 1-5, 7-9, 21), as well as 
associated innate signaling proteins such as myeloid differentiation primary response 88 
(MyD88) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) 
(Goldsmith and Jobin, 2012).  However, functional conservation has not been completely 
confirmed.  Moreover, studies of zebrafish homologs to known human immune-related 
genes and associated proteins is made possible through the use of extensive genomic 
resources that are continuously updated, due in part to repeated sequencing of the genome 
(Lieschke and Currie, 2007).   
Among characteristics relevant to the study of the innate immune system, the 
optical clarity of zebrafish early development may be the most significant.  As stated 
previously, zebrafish remain naturally transparent until around 7 days post fertilization 
(Goldsmith and Jobin, 2012).  Using a simple dissecting microscope, internal organs in 
the developing larva can be observed.  This is of great use in mortality experiments, in 
which the state of the zebrafish cannot be determined externally, but must be determined 
internally by observing the heart.  The generation of the casper zebrafish line, which 
lacks both melanocytes and iridophores, has allowed for real-time imaging in adults as 
well (White et al., 2008).  Combined with sophisticated fluorescence technology that tags 
specific proteins or other cellular entities, fluorescence microscopy allows for the direct 
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observation of disease processes in real-time, proving to be an advantage over other 
model organisms (Goldsmith and Jobin, 2012).  
Even with the numerous benefits stated previously, there are still disadvantages 
associated with the zebrafish model.  The zebrafish is a relatively new and emerging 
model organism, and thus the number of available fish strains is significantly smaller than 
those available for higher vertebrates such as the mouse (Goldsmith and Jobin, 2012).  
Furthermore, the environmental conditions in which the zebrafish must live differs 
substantially from that of humans; fish must be raised in 28 ⁰C water containing ions at 
specific concentrations.  In regard to genetic studies, there are numerous gene duplicates 
throughout the genome, complicating forward and reverse genetic manipulation 
(Goldsmith and Jobin, 2012).  Thus, many characteristics prevent this model from 
providing a complete representation of human biological processes.   
Disregarding all costs and benefits, the zebrafish has provided tremendous bench-
to-bedside power, showing great promise in its utilization to generate biomedical 
treatments in human patients (Goldsmith and Jobin, 2012).  Favorably, zebrafish are 
susceptible to bacterial, mycobacterial, protozoan, and viral infection, which has led to 
the development of a variety of infectious disease models to date (Lieschke and Currie, 
2007).  For example, at the University of Maine, zebrafish have been used to investigate 
microbe-host interactions, including studies of the gram-negative bacteria Pseudomonas 
aeruginosa (Kim lab) and the fungus Candida albicans (Wheeler Lab).  Overall, 
zebrafish-based infectious disease models will continue to aid in targeted biomedical 
research, and, alongside other animal models, will hopefully lead to additional treatments 
in the future.   
13 
 
IMMUNITY 
As previously stated, the zebrafish immune system is highly homologous to that 
of humans.  Similarities extend to both branches of immunity; innate and adaptive (Fig. 
6).  This allows for the development of comprehensive disease models.  Furthermore, the 
temporal separation between the two branches allows for the sole study of innate 
immunity if desired (Goldsmith and Jobin, 2012).     
 The immune system must recognize, repel, and eradicate pathogens that enter the 
host through a variety of channels.  The outcome of an infection depends on the integrity 
and strength of the host immune system as well as the level of virulence associated with 
the infecting pathogen (Parkin, 2001).  The interactive network responsible for 
facilitating the immune response is comprised of lymphoid organs, cells, humoral factors, 
Fig. 6 Molecular and cellular components employed in the innate and/or adaptive immune 
responses (Dranoff, 2004) 
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and cytokines.  Improper functioning of these components can result in an underactive or 
overactive immune system, resulting in immunodeficiency, autoimmunity, or allergies 
(Parkin, 2001).   
The immune system is divided into the innate and adaptive responses, although 
this can be misleading as there is much interaction between the two in terms of chemical 
signaling and cellular interactions (Parkin, 2001).  The innate immune system is the first 
line of host defense, consisting of physical and chemical barriers, such as the skin, as well 
as molecular and cellular components, such as neutrophils and macrophages.  It occurs 
almost immediately upon infection and is comprehensive, targeting a broad range of 
pathogens.  The basic machineries of the innate response are highly conserved in nature, 
employed in a variety of species ranging from plants to mammals (Akira et al., 2006).  Its 
prevalence reveals its significance in survival (Parkin, 2001).   
The immunoglobulin (IG)-based adaptive immune response evolved exclusively 
in jawed vertebrates, providing antigen-specific protection to a wide array of pathogens 
(there is an alternative 
variable lymphocyte 
receptor (VLR)-based 
adaptive response 
observed in jawless 
vertebrates) (Herrin and 
Cooper, 2010).  Using 
highly specialized T and 
B lymphocytes, adaptive 
Fig. 7 The afferent and efferent branches of innate 
immunity and the corresponding humoral and cellular 
components (Beutler, 2004) 
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immunity facilitates specific immunologic effector pathways while generating 
immunologic memory.  It is this immunologic memory that enables the immune system 
to yield a relatively rapid yet extremely effective response to subsequent encounters with 
the same pathogen (Bonilla and Oettgen, 2009).  Overall, this second line of defense is 
much more effective at eliminating specific pathogens, yet is not immediately activated 
upon infection, and may take several days or weeks to develop (Parkin, 2001). 
Although there are obvious advantages associated with an active adaptive 
response, initiation of adaptive immunity does not occur without help from the innate 
immune system.  Specifically, leukocytes and phagocytes help activate specialized 
adaptive immune cells through cytokine signaling and antigen presentation, respectively 
(Tosi, 2005).  However, in the majority of infections, this is not necessary. The innate 
immune cells activated during the inflammatory response succeed in ridding the host of 
the pathogen without having to initiate the adaptive response (Janeway and Medzhitov, 
2002).  This is made possible through the use of cellular and humoral components (Fig. 
7).  These components include a wide range of evolutionarily conserved receptors and 
gene products that, due to their critical importance in survival, have been extensively 
studied.  
Of utmost importance in the study of immune signaling and innate immunity, the 
evolutionarily conserved pattern-recognition receptors (PRRs) are expressed in innate 
immune cells and recognize microbial components known as pathogen-associated 
molecular patterns (PAMPs) (Akira et al., 2006).  PAMPS are structural molecules that 
are essential for the survival of the associated microorganism, leaving little room for 
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disruptive evolution-based alterations.  Examples of PAMPs are bacterial cell wall 
components and viral genetic material (Beutler, 2004).   
An essential class of PRRs is the group consisting of Toll-like receptors (TLRs).  
TLRs are type 1 integral membrane glycoproteins consisting of an extracellular leucine-
rich binding domain and an intracellular cytoplasmic signaling domain (Akira et al., 
2006).  TLRs recognize a variety of PAMPs, ranging from bacterial lipoproteins to viral 
double-stranded RNA (Moresco et al., 2011).  Binding of these PAMPs results in 
dimerization and induction of intracellular signaling cascades facilitated by adaptor 
molecules, often including MyD88, mal, TRIF, or TRAM.  The end result of such a 
cascade generally includes the activation of transcription factors, such as NF-κB, and 
subsequent release of signaling cytokines, such as interleukins and interferons (Tosi, 
2005).   
Pathogen recognition receptors, including TLRs, bind only to specific PAMPs.  
Therefore, each class of microorganism is recognized by a specific subset of membrane-
bound and cytosolic receptors, resulting in specialized branches of innate immunity.  One 
of these branches is responsible for eliminating viral infection and is known as the 
antiviral innate immune response.   
 
ANTIVIRAL INNATE IMMUNITY 
 Viruses are highly infectious pathogens that manipulate host cell machinery for 
survival.  Therefore, it is critical to express viral sensing PRRs in multiple cellular 
compartments, ready to recognize and quickly respond to a variety of viruses during the 
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early stages of infection.   While viral proteins are indeed responsible for triggering the 
viral innate immune response, viral nucleic acids are the predominant activator of a 
number of antiviral PRRs (Thompson et al., 2011).  These antiviral PRRs include TLRs, 
retinoic acid-inducible gene I-like receptors (RLRs), nucleotide oligomerization domain-
like receptors (NLRs) and cytosolic DNA sensors; all of which lead to the production of 
type-1 interferons or other inflammatory cytokines (Thompson et al., 2011).   
The antiviral TLRs have been extensively characterized and are critical for 
sensing viruses in the extracellular environment and within endosomal vesicles (Fig. 8).  
Those embedded in the plasma membrane (TLR2 and TLR4) often detect viral proteins 
and lipids associated with viral entry, while those embedded in endosomal membranes 
(TLR3, TLR7, TLR8, TLR9) detect nucleic acids released upon viral uncoating 
(Thompson et al., 2011).  Thus, the TLRs act as the first wall of defense and sense a viral 
presence early on in the viral life cycle.   
The remaining antiviral PRRs are located in the cytosol and detect genetic 
material of viruses replicating and residing there (Fig. 9).  This includes the RLRs and 
cytosolic DNA sensors, which regulate transcription factors responsible for the 
production of interferons and cytokines, similar to TLRs.  Also included are the NLRs 
and the absent-in-melanoma-2 (AIM2) protein, which are responsible for triggering  
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caspase-1-dependent maturation of pro-inflammatory cytokines IL-1β and IL-18 through 
the formation of inflammasomes (Thompson et al., 2011).   
Therefore, activation of all antiviral PRRs, no matter the receptor family, leads to 
the induction of complex signaling cascades that eventually regulate the production of 
certain cytokines.  This includes synthesis of type-1 interferons (IFN-α/β), which are 
Fig. 8 Viral recognition at the cell surface and within endosomes by Toll-like 
receptors (TLRs).  TLR2 recognizes a variety of viruses, signaling through MyD88-
dependent MAPK and NF-κB pathways.  TLR4 recognizes viral proteins and signals 
through both MyD88-independent and MyD88 dependent pathways.  The MyD88-
dependent pathway results in transcriptional regulation of inflammatory cytokines 
while the independent pathway proceeds via TRAM/TRIF and the IKK-related 
kinases, resulting in IRF3 activation and subsequent type 1 IFN production.  The 
endosomal receptors (TLR3, TLR7, TLR8 and TLR9) recognize viral nucleic acids 
and produce type 1 IFN through IRF3 or IRF7 activation (Thompson et al., 2011) 
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critical to the antiviral response (Thompson et al., 2011).  Newly synthesized IFN-α/β is 
released into the extracellular environment where it induces an ‘antiviral’ state in 
neighboring cells.  This is completed through yet another signaling pathway initiated by 
the interferon heterodimeric receptor, comprised of interferon alpha receptor 1 (IFNAR1) 
and interferon alpha receptor 2 (IFNAR2) (Randall and Goodbourn, 2008).  Key players 
downstream of this receptor include members of the Janus/just another kinase (JAK) 
family as well as the signal transducers and activators of transcription (STAT) family.  
 This pathway leads to the activation of the IFN-stimulated response element 
(ISRE) and subsequent synthesis of antiviral proteins (Randall and Goodbourn, 2008).  
Fig. 9 Pattern recognition receptors (PRRs) of the cytosol and nucleus. Cytosolic 
viral DNA sensors include gamma-interferon-inducible protein 16 (IFI16), DNA-
dependent activator of IFN-regulatory factors (DAI), RNA polymerase III, leucine-
rich repeat flightless-interacting protein 1 (LRRFIP1), DEAH box helicase 9 
(DDX9) and DDX36.  Cytosolic viral RNA sensors include retinoic acid-inducible 
gene (RIG-I) and melanoma differentiation-associated gene 5 (MDA5).  All DNA 
sensor pathways converge on the stimulator of interferon genes (STING) while all 
RNA sensor pathways converge on the mitochondrial antiviral signaling protein 
(MAVS).  The absent in melanoma-2 (AIM2) protein and the nucleotide-binding 
domain and leucine-rich repeat containing pyrin domain containing 3 (NLRP3) 
protein sensor promote the formation of inflammasomes which facilitates the 
release of IL-1b and IL-18.  (Thompson et al., 2011) 
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This includes protein kinase R (PKR), which inhibits viral translation and induces 
apoptosis, and Mx, which restricts viral replication, as well as a host of other factors that 
amount to an antiviral state within the cell (Randall and Goodbourn, 2008).  In addition 
to establishing antiviral defenses in target cells, IFN-α/β activates effector-cell function 
and promotes development of the adaptive immune response, providing the most 
advanced and integrated antiviral response possible (Randall and Goodbourn, 2008).  
 Even after establishing a variety of antiviral defenses, viruses find numerous ways 
to evade the IFN response.  This includes interfering with host gene expression, blocking 
IFN-induction cascades, inhibiting IFN signaling, blocking the action of IFN-induced 
enzymes, and replicating in a way that is largely insensitive to the action of IFN (Randall 
and Goodbourn, 2008).  Fortunately, the overlapping nature of many of the antiviral 
defense pathways seems to be a way to avoid viral evasion mechanisms (Thompson et al., 
2011).  This constant battle between viral evasion and host recognition is the subject of a 
great number of studies. 
 With regard to the present study, the molecular interactions of signaling 
cascades associated with a select number of the antiviral PRRs are of great interest.  
Therefore, these individual antiviral pathways will be reviewed in detail.   
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TOLL-LIKE RECEPTOR 3 (TLR3) 
 TLR3 is widely expressed in innate immune cells with the exception of 
neutrophils and plasmacytoid dendritic cells (pDCs) (Thompson et al., 2011).  The 
location of TLR3 within the cells changes depending on the type of immune cell.  For 
example, TLR3 relocalizes from the endoplasmic reticulum (ER) to endosomes in 
myeloid dendritic cells (mDCs) and to lysosomes in bone marrow-derived macrophages, 
while trafficking to the plasma membrane in others (Randall and Goodbourn, 2008).  
These cellular locations are ideal for detecting viral dsRNA before the viral replication 
process, both in the extracellular space as well as inside endosomes as viral uncoating or 
degradation occurs.   
 Interestingly, TLR3 is not known to recognize dsRNA viruses, as studies using 
reovirus displayed no difference in survival between TLR3-deficient and wild type mice 
upon infection (Thompson et al., 2011).  Instead, TLR3 is known to have a significant 
role in DNA virus detection.  During viral infection, it is hypothesized that bidirectional 
transcription of the opposing DNA strands produces dsRNA, which acts as the TLR3 
ligand.  This reveals the potential significance of TLR3 in antiviral pathways involving 
some of the world’s most notorious viruses, including herpes virus HSV-1 (Thompson et 
al., 2011).  Curiously, TLR3 recognition even extends to some ssRNA viruses, including 
influenza A virus (IAV).  While the TLR3-mediated inflammatory response aids in the 
defense against many of these viruses, TLR3 signaling appears to actually assist others, 
including influenza, where TLR3 activation is directly linked to a decrease in host 
survival (Thompson et al., 2011).  Therefore, activation of TLR3 has numerous 
consequences, all of which develop out of a very complex signaling cascade (Fig. 10).   
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Unlike other TLRs, this signal cascade does not begin with recruitment of MyD88 
(Randall and Goodbourn, 2008).  Instead, upon binding of dsRNA, dimerization and 
tyrosine phosphorylation of the receptor leads to the recruitment of a protein known as 
Toll-interleukin (IL)-1-resistance (TIR) domain-containing adaptor inducing IFN-β 
(TRIF), as well as phosphatidylinositol 3 (PI3) kinase.  Recruitment of TRIF is critical, as 
it activates two separate arms of the IFN-induction pathway; the NF-κB and IRF-3 
cascades (Randall and Goodbourn, 2008).   
 In the NF-κB cascade, activation of TRIF leads to the recruitment of tumor 
necrosis factor receptor-associated factor 6 (TRAF6) and its subsequent activation, after 
which TRAF6 initiates its own polyubiquitination, as well as the polyubiquitination of 
another signaling protein known as receptor-interacting protein 1 (RIP1) (Randall and 
Fig. 10 TLR3 dependent signaling.  Binding of double stranded RNA (dsRNA) to 
TLR3 results in the recruitment of TRIF and subsequent activation of either the IRF-3 
or NF-κB pathway.  Both pathways lead to the production of type 1 interferon IFN-β.  
(Randall and Goodbourn, 2008) 
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Goodbourn, 2008).  TAK1-binding proteins 2 and 3 (TAB2 and TAB3) recognize the 
polyubiquitin chains and chaperone transforming growth factor β-activated kinase 1 
(TAK1) to the developing protein complex.  In addition, the NF-κB essential modifier 
(NEMO) recognizes the polyubiquinated RIP1 protein (Randall and Goodbourn, 2008).  
NEMO is simply the γ subunit of the IκB kinase (IKK) complex; thus, upon binding of 
NEMO the associated α and β subunits are added to the protein complex as well.  Due to 
the structure of this newly formed protein complex, the IKKβ subunit and TAK1 are in 
close proximity to each other, and TAK1 phosphorylates IKK (Randall and Goodbourn, 
2008).  Phosphorylated IKK then propagates the signal by phosphorylating the inhibitor 
of NF-κB (IκB), leading to its ubiquitination and degradation.  Following degradation of 
its inhibitor, NF-κB is free to move into the nucleus where it can bind to the IFN-β 
promoter or the promoters of other inflammatory cytokines (Randall and Goodbourn, 
2008). 
 Activation of TRIF also leads to the recruitment of TRAF3, which initiates the 
IRF-3 cascade.   In this signal cascade, TRAF3 interacts with TRAF family member-
associated NF-κB activator (TANK), which recruits both TANK-binding kinase 1 (TBK-
1) and IKKi (Randall and Goodbourn, 2008).  The latter two kinases then phosphorylate 
and activate IRF-3 which moves into the nucleus and binds to the IFN-β promoter.  With 
the binding of IRF-3, NF-κB, and other co-factors to the IFN-β promoter, transcription is 
stimulated and IFN production begins (Randall and Goodbourn, 2008).   
 It is important to note that while TLR3 appears to be functionally conserved in 
zebrafish, the signaling pathway through which it activates NF-κB and induces IFN 
production differs from that of mammals (Phelan et al., 2005; Sullivan, 2006).  
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Specifically, zebrafish TRIF differs structurally from its mammalian homolog, causing it 
to bind to a different set of signaling molecules (Sullivan, 2006).  This should be taken 
into consideration when using zebrafish in immunological studies.   
 
TOLL-LIKE RECEPTOR 7/8 (TLR 7/8) 
Similar to TLR3, both TLR7 and TLR8 are closely related antiviral PRRs found 
embedded in the endosome.  Both receptors are activated by most long single-stranded 
RNA (ssRNA) molecules, as well as by the synthetic antiviral drug resiquimod (R-848) 
(Thompson et al., 2011).  Despite their similarity, activation using TLR7 or TLR8 
Fig. 11 TLR7 and TLR9 dependent signaling.  Upon recognition of ssRNA by TLR7 
or CpG DNA by TLR9, a MyD88-dependent signaling cascade occurs resulting in the 
activation of both IRF-7 and NF-κB.  Binding of these transcription factors to the IFN-
β promoter results in its transcription.  IRF-7 also binds to IFN-α promoters (Randall 
and Goodbourn, 2008) 
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receptor-specific agonists leads to different cytokine profiles within innate immune cells.  
It is also known that certain short dsRNAs preferentially activate TLR7 over TLR8 
(Thompson et al., 2011).  Overall, TLR7 has more often been the subject of research, and 
thus more is known about this receptor.   
TLR7 is expressed in only a few cell types, including pDCs, and unlike other 
TLRs which can traffic between membranes, TLR7 is located strictly on endosomes 
(Randall and Goodbourn, 2008).  At this location TLR7 is known to detect ssRNA upon 
viral uncoating/degradation.  Known ssRNA viruses recognized by TLR7 in this manner 
include human immunodeficiency virus (HIV) and influenza (Randall and Goodbourn, 
2008).  In some unique cases (e.g. vesicular stomatitis virus infection) viral replication 
precedes TLR7 activation. As viral replication normally occurs in the cytosol, this 
observation puzzled researchers.  However, it is now hypothesized that ssRNA 
intermediates produced in the cytosol during infection are engulfed by autophagy and 
recycled back to endosomes, where TLR7 is then activated (Randall and Goodbourn, 
2008).  Both of these TLR7 viral recognition pathways (termed exogenous and 
endogenous, respectively) lead to receptor activation and the subsequent development of 
an intricate signaling cascade (Fig. 11). 
 Similar to most PRRs, TLR7 activation results in the recruitment of the adaptor 
protein MyD88.  MyD88 then recruits a complex containing the kinases interleukin-1 
receptor-associated kinase 4 (IRAK-4), IRAK-1, TRAF6, and TRAF3 (Randall and 
Goodbourn, 2008).  Through this assembled complex, two pathways result.  One involves 
TRAF6 recruitment of the TAK1-TAB2-TAB3-NEMO and IKK complex utilized in the 
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TLR3 pathway.  This again results in activation of NF-κB followed by promoter binding 
and regulation of IFN transcription (Randall and Goodbourn, 2008).   
The alternative pathway stems from high constitutive expression of IRF-7 rather 
than IRF-3 in pDCs.  The previously described MyD88-IRAK-4-IRAK-1-TRAF6 
complex binds directly to IRF-7, resulting in its polyubiquitination by TRAF-6 and 
subsequent interaction with RIP-1 (Randall and Goodbourn, 2008).  IRAK-1 then 
phosphorylates IRF-7 in a TBK/IKKi-independent manner.  Still associated with MyD88, 
TRAF6, and IRAK-1, the now activated IRF-7 complex moves into the nucleus where it 
binds to the IFN-β promoter.  Similar to the TLR3 cascade, this binding of IRF, along 
with the binding of NF-κB and other cofactors, regulates the production of type-1 IFN 
and thus initiates the antiviral response (Randall and Goodbourn, 2008).   
Zebrafish TLR7 shares the same characteristic structure with mammalian TLR7, 
including high similarity in the toll/interleukin-1 receptor (TIR) domain.  Therefore, 
receptor function, including MyD88 interaction, is thought to be conserved.  
Interestingly, there are two splice variants of TLR7, and two distinct TLR8 homologs in 
zebrafish (Jault et al., 2004).  Such differences necessitate critical changes in 
experimental design.   
 
TOLL-LIKE RECEPTOR 9 (TLR9) 
The last antiviral PRR located on the endosome is TLR9.  TLR9 is similar to 
TLR7/8 in that it utilizes the same downstream signaling cascade (Fig. 11).  However, 
instead of ssRNA, TLR9 recognizes unmethylated deoxycytidylate-phosphate-
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deoxyguanylate (CpG) motifs in viral and bacterial DNA (Thompson et al., 2011).  
Whereas host genomic DNA is methylated at these CpG motifs, viral genomic DNA is 
not, informing the innate immune system of its foreign nature.  Many DNA viruses 
activate TLR9 upon viral uncoating or degradation within the endosome, including 
murine cytomegalovirus (MCMV) and Epstein-Barr virus (EBV).  TLR9 is even known 
to play a role in the antiviral response to herpes simplex virus type 1 (HSV-1) and HSV-
2, although this is still under investigation (Thompson et al., 2011).   
Depending on within which innate cell type TLR9 activation occurs, the 
associated signaling cascade can change slightly.  For example, due to endosomal 
restrictions, mDCs utilize IRF-1 rather than IRF-7.  Further, in pDCs, IRF-5 is activated 
upon both TLR7 and TLR9 stimulation in addition to IRF-7, and therefore also 
contributes to IFN production (Randall and Goodbourn, 2008).  It is thus important to 
note the flexible nature of TLR signaling as its mechanisms and outcomes change 
depending on a number of factors, including cell type and virus. 
Due to structural changes resulting from evolutionary divergence, the sequence 
motif that stimulates TLR9 changes among different species (Klinman, 2006).  For 
example, while mouse TLR9 is stimulated by a DNA motif consisting of two 5’ purines, 
the umethylated CpG, and then two 3’ pyrimidines, human TLR9 is stimulated by either 
TCGTT or TCGTA.  Furthermore, mouse TLR9 is expressed in macrophages and other 
myeloid cells, while human TLR9 is not, indicating that cell populations expressing 
TLR9 vary among species (Klinman, 2006).   
There are three structural classes of synthetic CpG oligodeoxynucleotides (ODNs) 
known to stimulate human TLR9: class A, B, and C (Klinman, 2006).  All three contain 
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distinct CpG motifs, resulting in class-specific cellular effects.  For example, class A 
ODNs preferentially stimulate IFN-α production in pDCs, while class B ODNs trigger B 
cell activation and support the production of TNF-α (Klinman, 2006).  Class C ODNs 
cause a combination of class A and B effects.  Humans and other primates respond to the 
same broad classes of ODNs, while other mammals, such as mice, respond poorly to 
some (Klinman, 2006).  Therefore, it is important to choose the correct CpG ODN when 
planning an experiment.   
In zebrafish there is one known TLR9 homolog, and, similar to TLR7/8, its 
structure and function appear to be relatively conserved (Jault et al., 2004).  This makes 
investigating TLR9 function in zebrafish relatively simple, and allows for straightforward 
comparisons to mammalian TLR9 function.   
 
MELANOMA DIFFERENTIATION-ASSOCIATED GENE 5 (MDA-5) 
Adding to the flexibility and complexity of antiviral PRR sensing, cytosolic 
nucleic acid sensors are perfectly positioned to detect virus after the process of cell entry.  
This includes sensors dedicated to the detection of either foreign DNA or RNA.   
Detection of intracellular viral RNA is delegated to the RLR family of DExD/H box 
RNA helicases, of which there are three members; retinoic acid-inducible gene (RIG-I), 
MDA5, and laboratory of genetics and physiology-2 (LGP-2) (Thompson et al., 2011).  
RIG-I and MDA-5 are very similar in structure and response, and are known for 
their tandem N-terminal caspase activation and recruitment domains (CARDs) 
(Thompson et al., 2011).  However, the two receptors recognize different forms of viral 
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RNA, and thus recognize different classes of RNA viruses.  RIG-I is stimulated by 5’-
triphosphorylated, uncapped ssRNA, a common feature of vesicular stomatitis virus 
(VSV), rabies virus, measles virus, influenza A virus, and hepatitis C virus (HCV) 
infection (Thompson et al., 2011).  In contrast, MDA-5 is stimulated by long dsRNA, and 
is known to recognize picornaviruses such as poliovirus (PV) and encephalomyocarditis 
virus (EMCV), as well as others (Thompson et al., 2011).  The final RLR family member, 
LGP-2, does not contain a CARD domain and is believed to be a possible regulator of 
RLR activity (Thompson et al., 2011).   
Following the CARD domain, MDA-5 contains a DExD/H box RNA helicase 
domain with ATPase activity and a C-terminal repressor domain (RD).  The RD domain 
Fig. 12 RLR family-dependent signaling.  Upon recognition of cytosolic RNA 
derivatives, both RIG-I and MDA-5 interact with the adaptor protein MAVS.  Similar 
to TLR3, the adaptor protein then activates the IRF-3 and NF-κB cascades, resulting in 
IFN production and the antiviral response.  (Randall and Goodbourn, 2008) 
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renders MDA-5 inactive through auto inhibition until stimulation by viral dsRNA causes 
an ATP-dependent conformational change and subsequent activation (Thompson et al., 
2011).  Upon activation, MDA-5 interacts with the adaptor protein mitochondrial 
antiviral signaling protein (MAVS) via CARD-CARD interactions on the mitochondrial 
membrane.  MAVS, similar to TRIF, then activates the exact same signaling cascades 
used in the IRF-3 and NF-κB branches of the TLR3 pathway (Fig. 12).  However, unlike 
TRIF, MAVS is also known to activate NF-κB through recruitment of TRADD, FADD, 
caspase-8 and caspase-10 (Thompson et al., 2011).  Also unique to intracellular RNA 
signaling, the NEMO protein of the IKK complex acts as an adaptor for both the IRF-3 
and NF-κB branches through its interaction with TANK (Randall and Goodbourn, 2008). 
Similar to the TLRs, a functionally conserved MDA5 homolog has been identified 
in zebrafish, alongside two splice variants, MDA5a and MDA5b (Zou et al., 2014).  The 
splice variants are believed to be involved in IFN production as well.  In particular, 
MDA5b is believed to enhance the interaction between MDA5 and MAVS.  This is a 
relatively new finding that requires further investigation (Zou et al., 2014).  Regardless, 
the evidence suggests that zebrafish can be used to study MDA5-dependent processes.       
Overall, the MDA-5 signaling pathway closely resembles that of the membrane-
bound TLRs.  This is significant, as the conserved nature of the innate signaling pathways 
allows for extensive cross-pathway interaction and regulation through the use of immune-
related proteins.   
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THE TNFAIP8L1 GENE FAMILY  
A relatively unexplored family of immune-related proteins, the tumor necrosis 
factor (TNF)-alpha-induced protein 8 (TNFAIP8) family is implicated in both innate 
immunity and immune homeostasis, as well as a number of human diseases (Lou and Liu, 
2011).  The family consists of four members: TNFAIP8, tumor necrosis factor alpha 
induced protein 8-like 1 (TNFAIPL1 or TIPE1), TIPE2, and TIPE3.  All four members 
share significant sequence homology and structural similarities (Lou and Lie, 2011).  
Characterization of TNFAIP8 and TIPE2 has revealed possession of dissimilar biological 
functions despite their significant structural similarities, while the other two members, 
TIPE1 and TIPE3, have remained largely uncharacterized (Lou and Liu, 2011).   
TNFAIP8, also known as SCC-S2, GG2-1, and MDC-3.13, was originally 
identified in a primary human head and neck squamous cell carcinoma (HNSCC) upon 
analysis of a patient’s expression profile (Patel et al., 1997).  Upon further investigation, 
TNFAIP8 was revealed to be a 21-kDa cytosolic apoptosis regulator protein expressed in 
various human cancer cell lines as well as in a number of normal human tissues, 
including lymphoid tissues, the placenta, heart, brain, adrenal gland, testis and skeletal 
muscle (Kumar et al., 2000; Kumar et al., 2004).  Expression of TNFAIP8 in these tissues 
is induced by either TNF-α, high glucose stimulation, or NF-κB activation.  Although the 
molecular mechanisms behind the transcriptional regulation of TNFAIP8 remain unclear, 
the chicken ovalbumin upstream promoter transcription factor I (COUP-TFI) was 
recently identified as a transcriptional repressor (Zhang et al., 2009).  The 
downregulation of COUP-TFI expression and subsequent relief of TNFAIP8 promoter 
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repression appears to be an important step in the TNF-α induction pathway of TNFAIP8, 
yet the mechanism is still unknown (Zhang et al., 2009).   
Similar to death effector domain (DED)-containing proteins, TNFAIP8 regulates 
caspase-mediated apoptosis (Lou and Liu, 2011).  DEDs are signature structures in 
caspases as well as numerous linker proteins such as the fas-associated death domain 
protein (FADD).  Upon activation of a member of the tumor necrosis factor receptor 
(TNFR) family, recruitment of FADD leads to the aggregation of a caspase protein 
complex, eventually resulting in the activation of executioner caspases, such as caspase-
3, which mediate cell death (Valmiki and Ramos, 2008).  Some DED-containing proteins, 
such as cellular FLICE-like inhibitory protein (c-FLIP), inhibit apoptosis by binding to 
FADD or caspase-8 and preventing the aggregation of pro-apoptotic protein complexes 
(Valmiki and Ramos, 2008).  
 For a long time it was believed that TNFAIP8 contained a DED, inhibiting 
apoptosis in a DED-dependent manner.  Indeed, the TNFAIP8 protein-protein interaction 
domain displays significant homology with DED II of the FLIP family of regulatory 
proteins (58% similarity compared to human FLIP).  However, high-resolution 
crystallography of TIPE2 revealed a large hydrophobic central cavity that is poised for 
cofactor binding (Zhang et al., 2009b).  Moreover, the TIPE2 domain is dissimilar from 
the common DED in structure and topology, and instead appears to be its mirror image, 
yielding functionality not commonly observed among the DED proteins (Zhang et al., 
2009b).  Due to high sequence homology, it is suggested that this unique domain is 
shared among all four TNFAIP8 family members, including TNFAIP8 (Zhang et al., 
2009b).  Therefore, although TNFAIP8 is a negative regulator of apoptosis, the exact 
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mechanism through which it inhibits caspase function is unknown.  Interestingly, the 
TNFAIP8 domain also showed significant homology to the corresponding domains of 
viral proteins dedicated to inhibiting similar apoptotic events, further supporting its 
inhibitory role (Kumar et al., 2000).   
As a negative regulator of programmed cell death, TNFAIP8 is considered to be 
an oncogene in human cancers.  Indeed, overexpression of TNFAIP8 has been observed 
in various cancer types, including breast and lung cancer (Lou and Liu, 2011).  The 
associated increase in TNFAIP8 production results in increased inhibition of TNF-α 
induced apoptosis and thus prolongs cell survival.  Depletion of TNFAIP8 expression in 
tumors appears to decrease their tumorigenicity, and thus may present a future target in 
cancer treatment (Lou and Liu, 2011). 
Additionally, other cellular interactions involving TNFAIP8 are beginning to 
surface. For example, a recent study revealed its interaction with the Gαi subunit in the 
Gαi-coupled dopamine-D2short (D2S) receptor-mediated pathway, resulting in cell death 
reduction and cell transformation enhancement (Laliberte et al., 2010).  In addition to 
apoptotic regulation, TNFAIP8 appears to play a role in innate immune signaling, as 
demonstrated in a study attempting to identify the genes associated with susceptibility to 
Staphylococcus aureus in A/J mice. This study found that TNFAIP8 is located on a 
quantitative trait locus (QTL) on chromosome 18 and affects expression of cytokines in 
mouse macrophages when exposed to S. aureus (Ahn et al., 2010).  As more studies 
surface, TNFAIP8 repeatedly appears to be a multi-functional cytosolic protein involved 
in apoptosis and immune homeostasis.  The inhibitory, multi-functional nature of 
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TNFAIP8 is also observed in TIPE2, the only other characterized member of the 
TNFAIP8 family.   
Although TNFAIP8 and TIPE2 share 78% amino acid sequence similarity, their 
cellular functions are extremely different (Sun et al., 2008).  TIPE2 is a negative 
regulator of inflammation, interacting with both the T cell receptor (TCR) and TLR 
pathways in the cytoplasm (Sun et al., 2008).  Specifically, TIPE2 inhibits activation of 
NF-κB and activating protein-1 (AP-1) by targeting upstream signaling complexes 
containing caspase-8, but not through direct protein-protein interactions.  Instead, TIPE2 
most likely binds to a cofactor associated with immunocyte activation, indirectly 
interacting with caspase-8 (Zhang et al., 2009b).  Through this process, TIPE2 negatively 
regulates macrophage TLR2, TLR3, TLR4, and TLR9 signaling (Freundt et al., 2008).   
TIPE2 expressed in immune cells is also found bound to Rac GTPases in an 
inhibitory manner.  Reduced levels of TIPE2 via TLR3 stimulation causes the removal of 
the TIPE2 inhibitory effect on Rac GTPases (Sun et al., 2012).  This allows for the 
subsequent activation of the downstream pathway through Phosphatidylinositol 3-Kinase 
(PI3K), leading to the production of type 1 IFN and proinflammatory cytokines  (Sun et 
al., 2012).  Involvement in the TLR-Rac signaling pathway supports not only regulatory 
function in cytokine production, but supports involvement in other Rac controlled cellular 
functions, including phagocytosis and oxidative burst, in which it plays a similar 
inhibitory role (Wang et al., 2012).  Interestingly, TIPE2 also positively regulates Fas-
mediated apoptosis and antigen receptor-induced cell death (AICD) through mechanisms 
not yet clearly understood.  Therefore, TIPE2 has numerous roles in immune 
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homeostasis, many demonstrating its critical role in the reduction of inflammation (Lou 
and Liu, 2011).   
Improper functioning of TIPE2 reveals the significance of its anti-inflammatory 
role.  For example, TIPE2-deficient mice suffer from chronic inflammatory disease with 
such symptoms as progressive weight loss and multiple organ inflammation (Sun et al., 
2008).  Moreover, the abnormal expression of TIPE2 in humans is linked to systemic 
autoimmunity, diabetic nephropathy, and hepatitis B (Li et al., 2009; Zhang et al., 2010a; 
Xi et al., 2011).  Not surprisingly, TIPE2 is predominantly expressed in cells of the 
immune system, especially in T lymphocytes and monocytes such as macrophages (Lou 
and Liu, 2011).  It is within these cells that proper functioning of TIPE2 prevents immune 
hyper-responsiveness.  Curiously, human TIPE2 is also expressed in a variety of non-
immune cell types, including neurons, squamous epithelial cells in the esophagus and 
cervix, and glandular epithelial cells in the stomach, colon, and appendix (Zhang et al., 
2011).  This expression pattern suggests that TIPE2 possesses alternative non-immune 
functions that remain to be discovered (Lou and Liu, 2011).   
The biological functions of the remaining two members of the TNFAIP8 family, 
TIPE1 and TIPE3, have been relatively unexplored.  Identified in 2008, both share high 
sequence homology with TIPE2 and are also believed to be expressed in the cytoplasm 
(Lou and Liu, 2011).  While no other information is available on TIPE3, the expression 
profile of TIPE1 has revealed information on its possible functions (Cui et al., 2011).  
Specifically, TIPE1 is expressed in a variety of tissues in mice, including neurons, 
hepatocytes, and muscular tissues.  Unlike TIPE2, TIPE1 is only expressed in a select 
range of immune cells, such as monocytes in the T cell zone (Cui et al., 2011).  In 
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zebrafish, TIPE1 is expressed in areas critical to immune development during larval 
stages, and is expressed in myeloid and lymphoid cells at 30 days post fertilization 
(Sullivan, unpublished).  Interestingly, high levels of TIPE1 mRNA were also found in 
numerous human carcinoma cell lines, suggesting a possible role in carcinogenesis, 
similar to TNFAIP8 (Cui et al., 2011).    
Additionally, TIPE1 is considered to have a role in TNF-α mediated necrosis, a 
programmed cell death pathway controlled by RIP1 and RIP3 kinases (Hitomi et al., 
2008; Kaczmarek et al., 2013; 
Christofferson and Yuan, 2010; Li 
et al., 2012).  Upon TIPE1 
knockdown (KD) in the murine 
L929 and NIH3T3 cell lines, 
necroptosis was inhibited.  
Therefore, it appears that TIPE1 
function enhances necroptotic cell 
death in these cell lines.   
Intriguingly, necroptosis has 
recently been identified as an 
antiviral mechanism (Dunai et al., 2011).  Thus, TIPE1 involvement in necroptosis may 
indicate further antiviral function.   
Previous studies in the Kim laboratory have demonstrated the significance of 
TIPE1 in the antibacterial innate response and zebrafish development (Sullivan, 
unpublished).  Knockdown of TIPE1 in zebrafish produces a distinctive developmental 
Fig. 13 Zebrafish larvae injected with mCherry 
tagged Pseudomonas aeruginosa 50 hours post 
fertilization.  Image taken 20 hours post 
infection.  (A) Control fish with normal 
phenotype and controlled infection.  (B) TIPE1 
KD fish with abnormal phenotype and visible 
systemic infection (Sullivan, unpublished) 
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phenotype (Fig. 13) while diminishing the number of neutrophils circulating in the blood 
stream.  Furthermore, infection with Pseudomonas aeruginosa yields a much higher 
mortality rate in KD fish, demonstrating its significance in survival after bacterial 
infection (Sullivan, unpublished).  In addition, RAW 264.7 cell exposure to LPS resulted 
in a TIPE1 expression profile extremely similar to that of TIPE2.  That is, stimulation of 
TLR4 decreased expression of TIPE1 and TIPE2 (Sullivan, unpublished).  Therefore, 
TIPE1 appears to have a critical role in innate immunity, as well as an unknown 
association with the TLR4 pathway that may follow a mechanism similar to that of 
TIPE2.   
Other recent findings in the Kim laboratory reveal an exciting new link between 
TIPE1 and tumorigenesis/ 
angiogenesis (Sullivan, 
unpublished).  Angiogenesis, the 
development of blood vessels, is 
required for tumor growth and 
metastasis.  In order to initiate 
angiogenesis, tumors often 
overexpress proangiogenic factors, 
including vascular endothelial 
growth factor (VEGF) (Folkman, 
2002).  TIPE1 is now believed to 
inhibit the expression of VEGF, 
effectively blocking angiogenesis 
Fig. 14 TIPE1 MO-knockdown in zebrafish 
results in aberrant angiogenesis (A).  This may 
result from increased expression of VEGF 
zebrafish orthologs vegfaa and vegfab following 
TIPE1 KD.  RNA was collected 48 hpf and 
quantified using qRT-PCR (B) (Sullivan, 
unpublished).    
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(Fig. 14) (Sullivan, unpublished).  Morpholino (MO)-mediated knockdown of TIPE1 in 
Tg(fli1:GFP) zebrafish (fish line exhibits fluorescently labeled lymphoangiogenic 
vessels) caused visible aberrant blood vessel formation, supporting this claim (Fig 14).  
In addition, in situ hybridization revealed that the zebrafish TIPE1 orthologue is 
expressed throughout embryonic development, including within cells associated with 
angiogenesis (Sullivan, unpublished).  In summary, these findings establish a preliminary 
link between TIPE1 and cancer, and suggest the possibility that TIPE1 functions as a 
tumor-suppressor gene (Sullivan, unpublished). 
Collectively, studies suggest that TIPE1 is a cytoplasmic immune-related protein 
with a diverse set of cellular functions.  This includes roles in necroptotic cell death, 
antibacterial innate immunity and angiogenesis.  Its apparent multi-functional character 
conveys the possibility of additional unidentified immune-related functions.  Therefore, 
due to its known function in antibacterial innate immunity, it is of great interest to 
investigate TIPE1 function in other specialized branches of innate immunity. This 
includes its role in the antiviral innate response, which has yet to be explored.   Using 
reverse genetics and associated gene silencing techniques, an attempt can be made to 
identify and establish TIPE1 antiviral function in select model systems.    
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GENE SILENCING TECHNOLOGIES 
Genetic manipulation has long been a critical component of genetic research, 
utilized in both forward and reverse genetics.  Forward genetics employs mutagenic 
screens to find the genotype 
responsible for a known 
phenotype.  This often involves 
randomly affecting genes with 
chemical mutagens, selecting for 
aberrant phenotypes, and then 
searching for associated sequence 
changes on a previously mapped 
genome (Ekker and Akimenko, 
2010).  In contrast, reverse 
genetics employs gene silencing 
technologies to identify the phenotype of a known genotype (Ekker and Akimenko, 2010) 
(Fig. 15).  The purpose is to elucidate the function of a known gene, largely through 
observing the consequent effects of silencing the gene of interest.  Both forward and 
reverse genetic approaches are utilized in the zebrafish, making it an extremely important 
model in genetic studies (Ekker and Akimenko, 2010).  
Reverse genetic studies in zebrafish most often employ morpholino 
oligonucleotides (MO) to knockdown target gene function.  MOs are synthetic 
oligonucleotides composed of approximately 25 morpholine bases bound by a neutrally 
charged phosphorodiamidate backbone (Bill et al, 2009).  Although similar in structure to 
Fig. 15 Common targets for gene knockdown 
utilized in reverse genetic studies (Hertog, 
2005) 
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DNA and RNA oligomers, the neutral charge of the MO oligomer makes it much more 
stable in the cellular environment.  In addition, the altered backbone confers resistance to 
patrolling endogenous endonucleases, preventing degradation (Ekker and Akimenko, 
2010).  More importantly, the morpholine bases can still participate in Watson-Crick base 
pairing, enabling MOs to bind to cellular RNAs (Ekker and Akimenko, 2010).      
MO binding to target transcripts results in the formation of heteroduplexes that 
inhibit either initiation of translation or RNA splicing (Bill et al., 2009).  Translational 
blocking occurs when MOs bind to complementary mRNA sequences within the 5’ 
untranslated region (UTR), inhibiting ribosome assembly and thus initiation of 
translation.  The level of subsequent target gene knockdown can be assessed through 
binding of antibody to the associated protein (Bill et al., 2009).  Alternatively, splice 
blocking results from the binding of MOs to splice site junctions within pre-mRNA, 
consequently preventing interaction with mRNA splicing machinery (Lawson and Wolfe, 
2011; Ekker and Akimenko, 2010).  Due to the stage at which splice blocking interrupts 
target gene expression, efficiency of gene knockdown can be concluded by simply using 
RT-PCR analysis, rendering this method slightly advantageous over translational 
blocking, which requires antibody-dependent analysis (Lawson and Wolfe, 2011).   
Traditionally, MOs are injected into the early embryo at the 1 to 8 cell stage, 
allowing for ubiquitous delivery and universal knockdown of the target gene (Bill et al., 
2009).  However, gene knockdown is transient, only lasting up to 5 days post-fertilization 
(Ekker and Akimenko, 2010).  During those five days, splice blocking MOs inhibit 
zygotic transcripts, while translational blocking MOs inhibit both zygotic and maternal 
transcripts.  Thus, splice blocking more closely mimics observed mutations, while 
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translational blocking reveals phenotypes not normally observed in genetic screening 
(Bill et al., 2009). 
Despite the specificity and efficiency of MOs in zebrafish, there are limitations 
that deserve consideration.  For example, in smaller embryos it is sometimes difficult to 
repeatedly inject precise volumes of MO, resulting in inadequate replicates (Eisen and 
Smith, 2008).  More importantly, MO injection can result in off-target gene effects, 
interfering with the production of irrelevant gene products and thus producing the 
possibility that the newly observed phenotype is not the result of target gene knockdown 
(Eisen and Smith, 2008).  There are a number of options for instituting a control, such as 
injecting a MO that affects a gene not expressed in the cells of interest, but none are 
perfect (Eisen and Smith, 2008).  Instead, a common method used to verify the efficacy 
of the injected MO is through phenotypic rescue.  To rescue the phenotype, the gene 
product of interest must be introduced into the cell in a form that is unaffected by the 
MO.  This is usually accomplished by injecting RNA at the one-cell stage (Eisen and 
Smith, 2008).  For example, the normal phenotype of a gene targeted by a splice blocking 
MO is rescued simply by introducing mRNA (Eisen and Smith, 2008).  However, 
rescuing the phenotype of a gene targeted by a translational blocking MO is more 
difficult, as the mRNA must be modified by either removing the 5’ UTR or introducing 
silent mutations into the coding region prior to injection (Eisen and Smith, 2008).   
Since the development of MOs by Dr. James Summerton as a means of inhibiting 
the translation of RNA transcripts in vivo, their application in zebrafish-based genetic 
research has progressed well past this therapeutic effort.  MOs are now largely used in the 
discovery of genes through large-scale screening, in the determination of gene function, 
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and in the verification of mutant phenotypes (Bill et al., 2009).  Unfortunately, other 
genetic manipulation techniques, such as the use of RNA interference (RNAi), have 
proven to be problematic in zebrafish, causing numerous off-target effects (Ekker and 
Akimenko, 2010).  In contrast, the application of RNAi in cell culture has proven to be 
extremely effective, and is thus frequently used as a gene silencing technique in 
mammalian cells (Joseph et al., 2012).   
RNAi is a common mechanism of sequence-specific, post-transcriptional gene 
silencing in plants and animals.  It is believed to be a highly conserved, ancient biological 
process used by the immune system to protect the host genome from foreign genetic 
material, including transposons and viral RNA (Joseph et al., 2012).  Over the past 
decade, RNAi has become an extremely important genetic tool used to help determine 
gene function, similar to MOs.  However, the two gene silencing techniques differ greatly 
in their mechanism of action.   
RNAi commonly acts through small RNA duplex molecules called short 
interfering RNA (siRNA) (Fig. 16).  These small RNA molecules originate from the 
processing of foreign dsRNA molecules in the cytosol.  Specifically, the enzyme Dicer 
converts the long dsRNA into smaller (20-23 nucleotide) dsRNA pieces consisting of a 
guide and passenger strand, both exhibiting 3’ overhangs (Carthew and Sontheimer, 
2009).  The passenger strand is degraded while the guide strand binds to the argonaute 
protein of the RNA-induced silencing complex (RISC).  This silencing complex then 
recognizes target RNA through guide strand-mediated base pairing.  Subsequent RISC 
activity silences genes in a sequence-specific manner, often by simply degrading the 
RNA transcript (Carthew and Sontheimer, 2009).   
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In an experimental setting, siRNA, due to its net negative charge, must be 
introduced into cells through either transfection, electroporation, or viral gene transfer 
(Qiagen).  All deliver a 
means of passing 
through the cell 
membrane. However, 
transfection offers an 
extremely efficient way 
to introduce siRNA into 
the majority of cell 
types, including both 
adherent and 
immortalized cells 
(Qiagen).  Using this 
delivery method, the 
siRNA is packaged with liposomes to facilitate cellular uptake.  Specifically, the 
individual net charges drive the formation of siRNA-lipid complexes in which siRNA is 
encapsulated by a lipid bilayer (Qiagen).  These small complexes are then able to assist in 
the endocytosis of siRNA.  Interestingly, other cationic carriers have been synthesized to 
improve efficiency and denote specificity to particular cell types.  Overall, siRNA 
transfection provides a means of specifically knocking down target mRNA, with effects 
lasting up to one week and peaking at 2-3 days post-transfection (Qiagen).  
Fig. 16 The siRNA gene silencing pathway, 
demonstrating RISC-dependent degradation of the target 
gene product (Carthew and Sontheimer, 2009) 
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Unfortunately, siRNA induction can lead to off target gene effects, resulting in a need to 
establish a control in each experiment. 
 Both MO-mediated and siRNA-mediated gene knockdown provide methods for 
elucidating the function of genes using reverse genetics.  They are similar in their 
outcomes and disadvantages, yet dissimilar in their mechanisms of action and 
functionality in different model systems.  Therefore, we employed both gene silencing 
technologies using two separate model systems, the zebrafish (MO-mediated knockdown) 
and the RAW 264.7 (siRNA-mediated knockdown) cell line, in an attempt to discover the 
role of TIPE1 in the antiviral immune response.    
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MATERIALS AND METHODS 
Zebrafish Maintenance, Antisense Morpholino Injection, Viral Injection, and 
Mortality 
Zebrafish Maintenance.  Zebrafish embryos were maintained in 75 mL of egg water (60 
mg/L of Instant Ocean, Spectrum Brands, Madison, WI) at 28 ⁰C.  After viral injection, 
zebrafish larvae were maintained at 33 ⁰C.   
Antisense Morpholino Injection.  Antisense morpholino oligonucleotides were injected 
into zebrafish embryos at the 1 cell stage (0.5 to 1 hpf).  Two TIPE1 translation blocking 
morpholinos (TIPE1 #1 and TIPE1 #2) were injected simultaneously at 4 ng each in a 3 
nL injection.  The control MO was injected at 8 ng in 3 nL.  TIPE1 morpholinos were 
designed using Gene Tools, LLC (Table 1).   
Morpholino  Sequence (5’-3’) 
TIPE1 #1 GTG CTG AAC GAG TCC ATG ATG TCT C 
TIPE1 #2 CCC CTA TTT GAA CCG GAT ACA AGG C 
Control CCT CTT ACC TCA GTT ACA ATT TAT A 
 
Viral Injection.  At 48 hpf, embryos were dechorionated and fish were anesthetized in 
tricaine. Influenza A/PR/8/34 (H1N1, EID50 10^10.7) virus (Charles River, North 
Franklin, CT) was then injected (1.5 nL) through the tail vein in both control and TIPE1 
morphant embryos.  In the first experiment, 4.0 uL of IAV stock was added to a 10 uL 
total solution with PBS and 0.5 uL of 5% phenol red.  In the second experiment, 9.5 uL 
Table 1 Sequences of the two TIPE1 morpholinos injected simultaneously at the 1 cell 
stage, as developed by Gene Tools (Philomath, OR)   
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of IAV stock was added to a 10 uL total solution containing 0.5 uL of 5% phenol red.  
The control was injected with HBSS supplemented with phenol red.   
Mortality.  At 5 hours post viral injection, zebrafish were observed under a dissection 
microscope, and all dead larvae were removed.  These deaths were attributed to 
incidental trauma caused during the injection process.  The remaining live fish were 
counted and the number was recorded as Day 0.  At intervals of 24 hours, this process 
was repeated, recording the number of live fish each day until day 5, at which time the 
zebrafish were discarded.  The egg water was changed each day upon counting.   
Cell Culture, Transfection and Stimulation 
Cell Culture.  RAW 264.7 cells were maintained at 37 ⁰C in Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with fetal bovine serum (10%), penicillin/streptomycin 
(1%) and glutamax (1%).   Cells were passaged at a 1:10 ratio every 2 to 3 days.   
Transfection.  Transfection procedure follows the SignaGen GenMute siRNA 
transfection protocol.  After counting cells/mL with hemacytometer, cells were spun 
down and resuspended in the appropriate volume to yield 200,000 cells/well (1 mL per 
well) for 24 wells.  Cells were allowed to grow for 24 hours, after which the media was 
removed, and 0.5 mL of new media was added to each well and incubated at 37 ⁰C for 30 
minutes.  Both control (NC) and TIPE1 siRNA (L1) reagents were prepared during this 
time (Table 2).  In 600 uL working solution of transfection buffer, 9 uL of L1 (18 uL of 
NC) and 24 uL of GenMute reagent were added in order to yield a final siRNA 
concentration of 30 nM in 50 uL transfection buffer.  After a 15 minute incubation at 
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room temperature (RT), 50 uL of the siRNA complexes were added drop wise to each of 
12 wells.  Cells were incubated at 37 ⁰C for 24 hours.   
siRNA duplex Sequence 
L1 
(MMC.RNAI.N025566.12.1) 
     5’-     GGAGUGAUGCUACUGCAAACCAAGA-3’ 
     3’-CUCCUCACUACGAUGACGUUUGGUUCU-5’ 
Stimulation.  Stimulation of Toll-Like Receptors and Rig-I-Like Receptors with 
InvivoGen ligands followed manufacturer’s recommended concentrations (Table 3).  At 
24 hours post L1 transfection, MDA5 was stimulated in 12 wells with high molecular 
weight (HMW) Poly(I:C)/LyoVec at 200 ng/mL.  The old media was removed and 1 mL 
of new media supplemented with ligand or control was added to each well.  Stimulation 
of TLRs was not preceded by siRNA-mediated TIPE1 KD.  Instead, associated ligands 
and controls were added 24 hours post plating (200,000 cells/mL) to a total of 8 wells (4 
replicates each) in the same manner. 
Receptor MDA5 TLR9 TLR7/8 TLR3 
Ligand HMW 
Poly(I:C)/LyoVec 
ODN 
1585 
(Class A) 
ODN 
1826 
(Class B) 
ODN 
2395 
(Class C) 
R848 LMW 
Poly(I:C) 
Concentration 200 ng/mL 1 uM 1 uM 1 uM 1 ug/mL 10 ug/mL 
Exposure 
(hours) 
1, 24 6, 24  6, 24  6, 24  6, 24  6, 24  
 
Table 3 The agonists, associated concentrations, and exposure times chosen in order to 
stimulate the specific innate immune pathways in RAW 264.7 cells.     
 
Table 2 Sequence of TIPE1 siRNA used to knockdown gene expression in RAW 
264.7 cells, as synthesized by Integrated DNA Technologies (Coralville, Iowa)    
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RNA Extraction, cDNA Synthesis, and Quantitative Polymerase Chain Reaction 
(qPCR) 
RNA Extraction.  Cells were collected at 1 hour and 24 hours post MDA5 stimulation, 
and at 6 and 24 hours post TLR stimulation.  Media was removed using an aspirator, 
followed by the immediate addition of 800 uL of TRIzol.  RNA extraction was then 
completed according to the manufacturer’s protocol (Ambion).  RNA quality was 
evaluated using gel analysis (1.5% Agarose, 150 V for 18 min).  RNA quantity was 
determined using a NanoDrop spectrophotometer.   
cDNA Synthesis.   cDNA was synthesized from extracted RNA using the iScript cDNA 
synthesis kit (BioRad, Hercules, CA).    Samples were diluted 1:10 in 180uL of nuclease 
free water (MDA5 samples were diluted with 80 uL).   
qPCR.  Target genes were amplified and quantified in 10 uL total qPCR reactions using 
specifically designed primers (Table 4).  Each reaction included 5 uL of SsoFast 
EvaGreen master mix (BioRad, Hercules, CA) or Quanta Green FastMix (Quanta, 
Gaithersburg, MD) as the fluorescent dye, 0.2 uL of forward/reverse target gene primer 
(0.2 uM final concentration), and 4.8 uL of cDNA.  Quantification cycle (Cq) values 
were calculated by a CFX96 real-time detection system.  Analysis of Cq values through 
GraphPad Prism 6 revealed relative target gene expression compared to the control.   
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Gene  Forward Primer (5’-3’) Reverse Primer (5’-3’) 
TNFAIP8 GCA GCC TCA CGT CCA TGT GCC AGG TTT TTG GAA TTG 
AA 
TIPE1 CGG AAA ACT GAA GGC TTG 
AC 
GAG GAC TTT CTT CTG GGC 
CT 
TIPE2 GAA ACA TCC AAG GCC AGA 
CT 
GAA GGA CTC CAT GGT GCT 
TG 
TIPE3 CCA ACA TGC TGA TTG ATG 
ACA CC 
GAG AAT GCC AAT TTT GAT 
TGC CA 
GAPDH CGT CCC GTA GAC AAA ATG 
GT 
TTG ATG GCA ACA ATC TCC 
AC 
TNF CCC TCA CAC TCA GAT CAT 
CTT CT 
GCT ACG ACG TGG GCT ACA 
G 
IFNB1 TCC CTA TGG AGA TGA CGG 
AG 
ACC CAG TGC TGG AGA AAT 
TG 
IL6 GAT GGA TGC TAC CAA ACT 
GGA      
TCT GAA GGA CTC TGG CTT 
TG 
IL1B TGT GAA ATG CCA CCT TTT 
GA 
GGT CAA AGG TTT GGA AGC 
AG 
  
  
RESULTS 
TIPE1 plays a critical role in the zebrafish antiviral response.  To test whether TIPE1 
plays a role in the antiviral innate immune response, H1N1 IAV was injected into 
zebrafish following morpholino-mediated TIPE1 knockdown.  The number of surviving 
fish was determined every 24 hours, and the percent survival was calculated over a span 
of five days.  At this early stage in development, only the innate immune response is 
present in the larvae.  As expected, IAV infection in control fish caused a clear decrease 
in percent survival.  However, IAV infection of TIPE1 morphants caused a more severe 
decrease in survival as observed in experiment #2, and suggests that TIPE1 plays a 
critical role in the zebrafish antiviral innate response (Fig. 17).   
Table 4 List of qPCR primers designed using qPrimerDepot.  Gapdh served as the 
control.       
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Fig. 17 Percent survival curves of control and TIPE1 morphant zebrafish 
injected with diluted (experiment #1) and undiluted (experiment #2) IAV.  
Both graphs demonstrate that infected TIPE1 morphants had the lowest 
chance of survival.  There was a significant difference between percent 
survival of IAV infected control fish and IAV infected TIPE1 morphant 
fish in experiment #2, as determined by a Mantel-Cox test. 
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TIPE1 interacts with a variety of antiviral pathogen recognition receptors. 
TIPE1 and the MDA5 Pathway.  Having established TIPE1 function in antiviral innate 
immunity, it was of great interest to investigate TIPE1 function in specific antiviral innate 
pathways.   MDA5 is a cytosolic dsRNA sensor that detects the presence of viral genomic 
fragments.  By transfecting RAW 264.7 cells with the synthetic dsRNA molecule 
Poly(I:C)/LyoVec (HMW), the MDA5 pathway was stimulated in vitro.  By using a high 
molecular weight Poly(I:C), MDA5 was preferentially stimulated over other dsRNA 
receptors, as MDA5 selectively recognizes long dsRNAs (Kato et al., 2008).  RNA was 
then collected at 1 and 24 hours post transfection, and quantified using qPCR.  Relative 
expression of target genes compared to the control (Gapdh) was then calculated.  The 
results are preliminary, but demonstrate that cell exposure to poly(I:C) for 24 hours 
successfully stimulated MDA5 and increased expression of both IFNB1 and IL6 (Fig. 
18).  Furthermore, the TIPE1 siRNA treatment was successful in knocking down TIPE1 
expression, as demonstrated in the TIPE1 1 and 24 hour expression profiles.  Moreover, 
TIPE1 KD increased IL6 expression in both control and (24 hour) stimulated cells, while 
TIPE1 expression was decreased upon MDA5 stimulation.  
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Fig. 18 Relative expression profiles of target genes in RAW 264.7 cells 
after siRNA-mediated TIPE1 KD and/or poly(I:C)-induced MDA5 
stimulation.  Significance was tested using 2way ANOVA (Holm-Sidak’s 
multiple comparisons test).  Stimulation of MDA5 appears to decrease 
TIPE1 expression while TIPE1 KD increases cytokine expression (IL6 
24h), although results were not significant.    
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TIPE1 and the TLR9 pathway.  TLR9 is an endosomal DNA receptor that recognizes 
specific unmethylated CpG motifs found in foreign genomes.  The TLR9 receptor was 
stimulated in RAW 264.7 cells using three classes (A,B,C) of CpG ODNs, each with 
slightly different structures and cellular effects.  Following the same procedure, relative 
expression profiles of target genes were constructed for cells stimulated for 6 and 24 
hours (Fig. 19).  All ODNs stimulated TLR9 as demonstrated in the increase in IFN and 
cytokine expression.  TLR9 stimulation for 6 and 24 hours also resulted in a decrease in 
TIPE1 expression. 
 
Fig. 19 Relative expression profiles of target genes in RAW 264.7 cells after Class C 
ODN-mediated TLR9 stimulation for 24 hours.  All expression patterns are 
representative of data for all three ODNs at both time points.  TIPE1 expression is 
significantly decreased, as determined by an unpaired T test.   
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TIPE1 and the TLR7/8 pathway.  TLR7/8 are endosomal ssRNA receptors that detect 
segments of the viral genome.  The anti-viral imidazoquinoline compound R848 was 
used to stimulate TLR7/8 in RAW 264.7 cells for 6 and 24 hours.  The relative 
expression profiles show similarities with those of MDA5 and TLR9 (Fig. 20).   
 
 
Fig. 20 Relative expression profiles of target genes in RAW 264.7 cells after 
R848-mediated TLR7/8 stimulation for 24 hours.  Expression of all cytokines 
significantly increased, while TIPE1 expression significantly decreased by 
around 50%.   
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TIPE1 and the TLR3 pathway.  TLR3 is an endosomal dsRNA receptor that recognizes 
segments of the viral genome.     By using a low molecular weight (LMW) poly(I:C) 
agonist, TLR3 was targeted for stimulation rather than the cytosolic MDA5.  Again, 
relative expression profiles showed similar expression patterns compared to previously 
stimulated antiviral PRRs (Fig. 21).    
 
Fig. 21 Relative expression profiles of target genes in RAW 264.7 cells 
after poly(I:C)-mediated TLR3 stimulation for 24 hours.  Due to large 
error bars, data was largely insignificant, and extremely preliminary.  
Yet, TIPE1 expression significantly decreased upon stimulation with the 
removal of an outlier.   
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TIPE1 expression decreases upon antiviral TLR stimulation.  Although it appears that 
TIPE1 expression also decreases upon MDA5 stimulation, the observed decrease 
following TLR stimulation is much greater, as revealed by the individual TIPE1 
expression profiles derived from stimulation of TLR3, TLR7, TLR8, and TLR9 (Fig. 22).    
 
 
 
 
 
    
 
 
 
 
 
 
A B 
C 
Fig. 22 Relative expression profile of TIPE1 in RAW 264.7 cells after ODN-mediated 
TLR9 stimulation (A), poly(I:C)-mediated TLR3 stimulation (B), and R848-mediated 
TLR7/8 stimulation (C) for 24 hours.  All decreases in expression are significant as 
calculated by an unpaired T test.   
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DISCUSSION 
As viruses continue to cause devastating and often fatal diseases worldwide, the 
need to develop antiviral treatments is always present. The study of antiviral innate 
pathways is frequently involved in the development of such treatments, particularly when 
investigating the possible utility of recently discovered immune-related genes.  In the 
current study, the gene of interest, TIPE1, has been left largely uncharacterized since its 
discovery in 2008, yet its gene family has identified roles in immune homeostasis and 
innate immunity.   Therefore, employing the zebrafish as an in vivo model organism, the 
significance of TIPE1 in the antiviral innate response was investigated.  Additionally, in a 
set of preliminary experiments, the RAW 264.7 mouse macrophage cell line was 
employed as an in vitro model to study possible interactions between TIPE1 and specific 
antiviral pathways. 
Previous work completed by Dr. Con Sullivan in the Kim Lab revealed that 
TIPE1 plays a critical role in zebrafish antibacterial innate immunity. In a set of mortality 
experiments, zebrafish subjected to morpholino-mediated TIPE1 KD prior to injection of 
Pseudomonas aeruginosa survived at a lower rate than zebrafish solely infected with 
bacteria. Therefore, a similar procedure was completed to test the role of TIPE1 in the 
antiviral innate immune system.  Indeed, TIPE1 morphant zebrafish infected with H1N1 
IAV at 48 hpf exhibited a comparable decrease in survival (Fig. 17).   This decreased 
ability to fight off systemic viral infection demonstrated critical TIPE1 antiviral function.   
Having established TIPE1 function in the antiviral innate immune response, the 
mechanisms behind this function were investigated.  This required the study of specific 
antiviral PRR pathways.  Due to the speed and efficiency attributed to cell culture, the 
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RAW 264.7 mouse macrophage cell line was utilized to acquire preliminary data.  Also, 
by completing a targeted study using a well-established immune cell line, limitations 
associated with the use of a model organism were avoided.  In an attempt to establish a 
connection between TIPE1 and each of the four major antiviral pathways, the level of 
TIPE1 expression was quantified following specific PRR stimulation.  Consequent 
upregulation or downregulation of TIPE1 expression was indicative of interaction 
between TIPE1 and the associated antiviral signaling cascade. 
  The endosomal antiviral TLR receptors include TLR3, TLR7/8, and TLR9.  
Critical to the recognition of viral genomes during infection, these receptors recognize 
dsRNA, ssRNA, and unmethylated CpG DNA, respectively.  The synthetic derivatives 
chosen to stimulate each antiviral TLR (Table 2) successfully activated the associated 
pathways, as cytokine expression levels significantly increased following 6 and 24 hour 
exposure times (Fig. 19-21).   Interestingly, activation of each pathway resulted in a 
significant decrease in TIPE1 expression to various degrees (Fig. 21).  This suggests a 
possible inhibitory role, as activated signaling cascades often decrease the presence of 
inhibitory molecules in order to propagate the signal.  
A decrease in TIPE1 expression is also observed after MDA5 stimulation (Fig. 
18).  MDA5 is a cytosolic dsRNA sensor that belongs to the RLR family of PRRs 
responsible for the detection of viral genetic components within the cytosol.  Although 
the location and structure of MDA5 is significantly different from that of the TLR family, 
stimulation of MDA5 leads to the activation of transcription factors activated by the TLR 
pathways (Fig. 12).  Therefore, it is not surprising that stimulation of either receptor 
family may lead to similar cellular effects.   
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The suggested inhibitory nature of TIPE1 is further supported by the observed 
consequence of siRNA-mediated TIPE1 KD in the RAW 264.7 cells (Fig. 18).  Upon 
TIPE1 KD, IL6 expression (24 hour RNA collection) and IFNB1 expression (1 hour 
RNA collection) increases.  The TIPE1 protein therefore may inhibit the expression of 
inflammatory and antiviral cytokines by an unknown mechanism.  It is important to note 
that these data are preliminary, yet they reveal expression patterns that point towards the 
inhibitory nature of TIPE1. 
   TIPE2, another member of the TNFAIP8 gene family, has been characterized at 
a much higher level.  TIPE2 is a known negative regulator of inflammation through direct 
interaction with both the TCR and TLR pathways.  Specifically, the TIPE2 protein 
inhibits NF-κB and AP-1 activation by targeting upstream signaling complexes.  
Therefore, the similarities between the TIPE2 and TIPE1 expression profiles provide 
more evidence that TIPE1 also has an inhibitory function in the innate immune system 
(Fig. 19-21).  This parallel pattern in decreased expression is observed upon stimulation 
of both antibacterial (TLR4) and antiviral pathways, suggesting inhibitory TIPE2 and 
TIPE1 function in both branches of innate immunity (Con Sullivan, unpublished; Fig 18-
21).  However, despite the fact that members of the TNFAIP8 gene family share high 
sequence homology, characterized members have clearly disparate immune functions.  
Therefore, it is highly likely that although TIPE1 and TIPE2 may share inhibitory 
function, their specific mechanisms and targets may be entirely different.   
Previous studies performed by Dr. Con Sullivan in the Kim Lab have revealed 
TIPE1 function in both angiogenesis and antibacterial innate immunity.  The current 
study proposes that TIPE1 also functions in the antiviral innate immune response.  
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Although the data suggest that TIPE1 is a negative regulator of the innate immune 
system, further study will be required to elucidate the mechanism of action.   
Similar to the other members of the TNFAIP8 gene family, TIPE1 appears to be 
an important multi-functional immune-related gene greatly involved in immune 
homeostasis.  Unfortunately, aberrant expression of homeostatic genes can have 
detrimental results, as atypical TNFAIP8 and TIPE2 expression has been observed in 
cancer and inflammatory disease, respectively.  Due to recent findings, it appears that 
abnormal TIPE1 expression could lead to similar diseases.  Therefore, it is critical to 
further elucidate TIPE1 function, as it could lead to targeted treatments for numerous 
illnesses.  The present study strongly suggests that future investigation of TIPE1 antiviral 
function could lead to new antiviral treatments.     
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